Financiere Des Professionnels Fonds D,Investissement Inc. Halozyme Therapeutics, Inc. Transaction History
Financiere Des Professionnels Fonds D,Investissement Inc.
- $1.66 Trillion
- Q2 2025
A detailed history of Financiere Des Professionnels Fonds D,Investissement Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Financiere Des Professionnels Fonds D,Investissement Inc. holds 10,130 shares of HALO stock, worth $583,994. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,130Holding current value
$583,994% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$1.02 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$740 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$349 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$225 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$212 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.03B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...